58 results on '"De, Arka"'
Search Results
2. Fingolimod, a sphingosine-1-phosphate agonist for the treatment of hepatopulmonary syndrome: Queries and concerns.
3. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis – Validation in an Indian Cohort.
4. NAFLD vs. MAFLD – It is not the name but the disease that decides the outcome in fatty liver.
5. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.
6. Who to Screen for Hepatitis C: That is the Question.
7. Combination of Locoregional Therapy (LRT) And Tyrosine Kinase Inhibitors (TKIS) is superior to LRT alone in improving the overall survival in Hepatocellular Carcinoma.
8. Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
9. Safety and Efficacy of Saroglitazar in Patients with Non-obese NAFLD: Open-label Randomized Control Trial.
10. EUS guided liver biopsy in patients with suspected cACLD and cirrhosis: a real-life observational study.
11. An enigmatic case of hypereosinophilia.
12. Urinary Proteomics Unveil Prognostic Biomarkers in Acute Kidney Injury with Decompensated Cirrhosis.
13. Molecular Characterization of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: Implications for Immunotherapy.
14. Hepatitis C and HIV Co-Infection in Prisons of Punjab.
15. FRI-231 Compared to complete abstainers, non-significant alcohol use may be associated with more severe liver disease in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)-The multicentre study of the indian consortium on MASLD
16. AGILE 3+ Score for Assessing Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) – Validation in an Indian Cohort.
17. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
18. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
19. Transition of AKI to CKD in cirrhosis – effect of baseline eGFR and unanswered questions.
20. Acute Esophageal Necrosis Caused by Candidiasis in a Patient with Systemic Lupus Erythematosus.
21. IgG4-Related Sclerosing Cholangitis with Cholecystitis Mimicking Cholangiocarcinoma: A Case Report.
22. DAAs and HBV/HCV coinfection: Glimmer of light and a few shades of grey.
23. Tuberculosis in Cirrhosis – A Diagnostic and Management Conundrum.
24. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF – An Open Label Randomized Clinical Trial.
25. Validation of AGILE-4 Score for Assessing Cirrhosis in Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD): An Interim Analysis of the Multicentric Indian Consortium on Nafld (ICON D) Study.
26. Validation of AGILE-3+ Score for Assessing Advanced Fibrosis in Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD): An Interim Analysis of the Multicentric Indian Consortium on NAFLD (ICON D) Study.
27. Has the time come for using MELD-Sarcopenia score?
28. Acute Viral Hepatitis with Prolonged Cholestasis: Role of steroids and Experimental Therapies in Management.
29. Effectiveness of Time-restricted Intermittent Fasting in Patients with Non-alcoholic Fatty Liver Disease - A Randomized Controlled Trial.
30. INASL–SAASL Consensus Statements on NAFLD Name Change to MAFLD.
31. THU-324 Differential apoptotic and non-apoptotic cell death profiles in alcohol associated liver disease and their prognostic impact on acute-on-chronic liver failure.
32. Lysosomal Acid Lipase Activity in Non-alcoholic Fatty Liver Disease as a Novel Diagnostic and Therapeutic Target: A Systematic Literature Review of Current Evidence and Future Directions.
33. THU-051 Extended validation of proteomics and machine learning guided biomarker discovery and pathway perturbations in infectionrelated acute-on-chronic liver failure.
34. SAT-295 Sarcopenia, frailty and growth hormone-insulin like growth factor axis among decompensated and alcohol-associated hepatitis patients.
35. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis—An Observational Study.
36. Invasive Pulmonary Aspergillosis and Tuberculosis Complicated by Hemophagocytic Lymphohistiocytosis - Sequelae of COVID-19 in a Liver Transplant Recipient.
37. Poor Applicability of MAFLD Criteria for Lean Patients with NAFLD in Real-life Practice.
38. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.
39. Bloody Lips - Gluing Bleeding Lower Lip Spider Angioma in Decompensated Cirrhosis.
40. Hepatic Angiosarcoma—Uncommon Presentation of a Rare Tumor and its Management by Interventional Radiology.
41. Prevalence, Predictors, and Outcomes of Esophageal Candidiasis in Cirrhosis: An Observational Study With Systematic Review and Meta-Analysis (CANDID-VIEW).
42. Exploring the Prevalence, Predictors and Impact of Bacterial Infections and Guiding Empiric Antimicrobial Decisions in Acutely Decompensated Cirrhosis (EPIC-AD): A-seminal.
43. Bedside Galactomannan Lateral Flow Assay (GM-LFA) for timely diagnosis of Invasive Pulmonary Aspergillosis In ACLF Patients.
44. Predictors of Coronary Artery Disease (CAD) In Potential Liver Transplant (LT) Recipients and Performance ofThe CAD-LT Score In Identifying A Risk-Based Strategy For CAD.
45. A comprehensive Analysis of the Impact of the Growth Hormone-insulin Like Growth Factor Levels on Complications, Autonomic Neuropathy, and Prognosis in Cirrhosis.
46. Impact of outpatient intensive nutrition therapy on survival and frailty in patients with Acute on Chronic Liver Failure - Randomised controlled trial.
47. An Observational Study to Determine the Combination of Precipitating Factors Predicting 30-Day Mortality in Acute-On-Chronic Liver Failure (ACLF), With Respect to Underlying Disease Etiology and definition of ACLF.
48. Endoscopic Ultrasound guided occlusion for large gastric varices Can we do away with coils?
49. Imaging and Endovascular Interventions for Portosystemic shunts in cirrhosis - An Overview.
50. Prevalence of Frailty in Patients with Hepatocellular Carcinoma: A real-world observational Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.